Skip to main content
Livermore
Livermore
ZHEN

Prometheus Biosciences, Inc.

RXDXDelisted Jun 16, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001718852

Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Prometheus Biosciences, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of RXDX: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1032116+15
Shares27.7M46.2K30.8M+3.19M (+11.6%)
Value$1.04B$1.75M$869.7M−$173.4M (−16.6%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Prometheus Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to RXDX in Q2 2022
InstitutionSharesValue% of portfolio
Sofinnova Investments, Inc.386,395$10.9M0.97%
Balyasny Asset Management LLC241,586$6.82M0.03%
5AM Venture Management, LLC182,370$5.15M1.27%
Sectoral Asset Management Inc172,505$4.87M0.98%
Millennium Management LLC107,742$3.04M0.00%
Weiss Multi-Strategy Advisers LLC79,757$2.25M0.07%
Two Sigma Investments, LP49,758$1.41M0.00%
Renaissance Technologies LLC49,600$1.40M0.00%
HRT Financial LP45,967$1.30M0.01%
J. Goldman & Co LP39,218$1.11M0.09%
Altium Capital Management LP39,000$1.10M0.47%
Long Focus Capital Management, LLC35,000$988.0K0.20%
Squarepoint Ops LLC32,688$923.0K0.01%
Gyon Technologies Capital Management, LP28,532$805.0K0.23%
Two Sigma Advisers, LP25,000$706.0K0.00%
UBS Oconnor LLC24,000$678.0K0.01%
Graham Capital Management, L.P.23,294$657.0K0.03%
Jump Financial, LLC19,200$542.0K0.02%
State Board of Administration of Florida Retirement System11,774$332.0K0.00%
Simplex Trading, LLC11,448$323.0K0.01%
HighVista Strategies LLC10,782$304.0K0.18%
Jane Street Group, LLC10,416$294.0K0.00%
Mirae Asset Global Investments Co., Ltd.10,049$283.0K0.00%
Principal Financial Group Inc8,910$251.0K0.00%
Dynamic Technology Lab Private Ltd8,130$230.0K0.03%
Amundi3,460$100.0K0.00%
The PNC Financial Services Group, Inc.98$3.00K0.00%
Harvest Group Wealth Management, LLC13$1.00K0.00%
Rockefeller Capital Management L.P.39$1.00K0.00%
Captrust Financial Advisors7$00.00%
Ellevest, Inc.12$00.00%

Sold out (16)

Institutions that held Prometheus Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of RXDX in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Deep Track Capital, LP245,000$9.25M
Kingdon Capital Management, L.L.C.100,000$3.78M
EAM Investors, LLC80,587$3.04M
EAM Global Investors LLC57,073$2.15M
Calamos Advisors LLC47,690$1.80M
Rafferty Asset Management, LLC43,860$1.66M
Cinctive Capital Management LP29,640$1.12M
SEI Investments Co19,262$727.0K
Dimensional Fund Advisors LP18,904$714.0K
Arrowstreet Capital, Limited Partnership11,684$441.0K
ProShare Advisors LLC9,650$365.0K
UBS Asset Management Americas Inc6,200$234.1K
Virtu Financial LLC5,311$201.0K
Prospera Financial Services Inc4,125$156.0K
Dark Forest Capital Management LP353$13.0K
TCI Wealth Advisors, Inc.133$5.00K

Not filed for Q2 2022 yet (2)

Institutions that held Prometheus Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RXDX in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC42,460$1.60M
Amalgamated Financial Corp.3,782$143.0K